108 Ablative Doses of Radiotherapy to the Prostate Gland and Metastatic Sites in De Novo Low Burden Metastatic Prostate Cancer
Benazir Mir Khan, Zahid Al-Mandhari(Royal Hospital), Sharjeel Usmani(Sultan Qaboos University Hospital), Muhsina Vellengara(Sultan Qaboos University), Mahmoud Alfishawy, Iqbal Al Amri, Hasan Al‐Sayegh(Sultan Qaboos University), Nadeem Pervez(Sultan Qaboos University)
Cited by 0
Related Papers
An Anatomical Site and Genetic-Based Prognostic Model for Patients With Nuclear Protein in Testis (NUT) Midline Carcinoma: Analysis of 124 Patients
|JNCI Cancer Spectrum|2019|231
Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study
|Blood|2018|165
A dose response analysis of a specific bone marrow concentrate treatment protocol for knee osteoarthritis
|BMC Musculoskeletal Disorders|2015|110
Provider Perspectives on Use of Medical Marijuana in Children With Cancer
|PEDIATRICS|2017|66
Genotype‐phenotype correlation and molecular heterogeneity in pyruvate kinase deficiency
|American Journal of Hematology|2020|66